Abstract:Cyclic nucleotides are important signaling molecules that play many critical physiological roles including controlling cell fate and development, regulation of metabolic processes, and responding to changes in the environment. Cyclic nucleotides are also pivotal regulators in immune signaling, orchestrating intricate processes that maintain homeostasis and defend against pathogenic threats. This review provides a comprehensive examination of the pharmacological potential of cyclic nucleotide signaling pathways within the realm of immunity. Beginning with an overview of the fundamental roles of cAMP and cGMP as ubiquitous second messengers, this review delves into the complexities of their involvement in immune responses. Special attention is given to the challenges associated with modulating these signaling pathways for therapeutic purposes, emphasizing the necessity for achieving cell-type specificity to avert unintended consequences. A major focus of the review is on the recent paradigm-shifting discoveries regarding specialized cyclic nucleotide signals in the innate immune system, notably the cGAS–STING pathway. The significance of cyclic dinucleotides, exemplified by 2′3′-cGAMP, in controlling immune responses against pathogens and cancer, is explored. The evolutionarily conserved nature of cyclic dinucleotides as antiviral agents, spanning across diverse organisms, underscores their potential as targets for innovative immunotherapies. Findings from the last several years have revealed a striking diversity of novel bacterial cyclic nucleotide second messengers which are involved in antiviral responses. Knowledge of the existence and precise identity of these molecules coupled with accurate descriptions of their associated immune defense pathways will be essential to the future development of novel antibacterial therapeutic strategies. The insights presented herein may help researchers navigate the evolving landscape of immunopharmacology as it pertains to cyclic nucleotides and point toward new avenues or lines of thinking about development of therapeutics against the pathways they regulate.

A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP

Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA

Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway

The Role of Bacterial Cyclic Di-Adenosine Monophosphate in the Host Immune Response

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

The Mechanism of Double-Stranded DNA Sensing Through the Cgas-Sting Pathway.

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING

Pharmacological potential of cyclic nucleotide signaling in immunity

Post-translational Control of Intracellular Pathogen Sensing Pathways

Cgas Facilitates Sensing of Extracellular Cyclic Dinucleotides to Activate Innate Immunity

The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity

Innate Immune Response to Cytoplasmic DNA: Mechanisms and Diseases.

Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing

cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.

Synthesis of All Possible Canonical (3 '-5 '-Linked) Cyclic Dinucleotides and Evaluation of Riboswitch Interactions and Immune-Stimulatory Effects

Synthesis of c-di-GMP analogs modified by ganciclovir and biological activity to induce type Ⅰ interferon

Detection of Cyclic Dinucleotides by STING.

cGAS goes viral: A conserved immune defense system from bacteria to humans

DNA Sensor Cgas-Mediated Immune Recognition

Pivotal Roles of Cgas-Cgamp Signaling in Antiviral Defense and Immune Adjuvant Effects

The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy